Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Fr Ophtalmol ; 41(8): 696-707, 2018 Oct.
Artigo em Francês | MEDLINE | ID: mdl-30217610

RESUMO

PURPOSE: The goal of our retrospective, single-center study of a case series was to compare the total, corneal, and internal astigmatism, and the visual acuity at one year after combined or stand-alone surgery consisting of iris fixation of an iris-claw intraocular lens (ARTISAN aphakia) in aphakic patients, according to whether the lens was fixated to the anterior (n=21) or posterior (n=51) surface of the iris. RESULTS: We did not find a significant difference between these two types of fixation for any of the studied variables. The surgically induced astigmatism was 1.67 D at 176° in group A versus 1.19 D at 11° in group P. CONCLUSION: Although this surgery creates additional corneal astigmatism, it has not been proven that it differs depending on the type of fixation of the iris-claw. If we adhere to the notion that the posterior fixated iris-claw decreases the risk of endothelial decompensation in case the implant becomes disenclavated, then reverse iris fixation of the iris-claw makes sense.


Assuntos
Astigmatismo/etiologia , Iris/cirurgia , Implante de Lente Intraocular/efeitos adversos , Implante de Lente Intraocular/métodos , Lentes Intraoculares/efeitos adversos , Idoso , Idoso de 80 Anos ou mais , Afacia Pós-Catarata/patologia , Afacia Pós-Catarata/cirurgia , Astigmatismo/epidemiologia , Astigmatismo/patologia , Feminino , Seguimentos , Humanos , Iris/patologia , Lentes Intraoculares/classificação , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Período Pós-Operatório , Estudos Retrospectivos , Acuidade Visual
2.
J Eur Acad Dermatol Venereol ; 26 Suppl 3: 52-60, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22512681

RESUMO

OBJECTIVE: The objective of this systematic review was to prepare for evidence-based recommendations on the use of vitamin D analogues, and their combination with topical steroids in psoriasis. METHODS: Literature systematic review performed in May 2011. The Cochrane, PubMed and Embase databases were systematically searched with different combinations: including Psoriasis AND calcipotriol expanded to all vitamin D analogues. To assess efficacy across studies, we used two predefined criteria to account for the numerous endpoints found in the literature, 'Treatment success' corresponding to 90% improvement in severity and 'Satisfactory response' corresponding to 75% improvement. We conducted a meta-analysis comparing the efficacy of vitamin D analogues plus topical steroids (VDS) vs. vitamin D analogues alone (VD). To determine the relative cost-efficacy of the topical drugs available on the market, cost/efficacy ratios were calculated for each product according to the approved therapeutic regimen. RESULTS: 51 articles were selected. The application duration varied between three to 52 weeks across studies. VD as monotherapy had a satisfactory response rate between 22% to 96% and a treatment success rate ranging from 4% to 40%. VDS had a satisfactory response rate between 35% to 86% and a treatment success rate ranging from 27% to 53%. A meta-analysis found a probability of success twice higher with VDS than with VD in adult plaque psoriasis. The cost/efficacy ratio was evaluated as 1.2-1.8 times higher for VDS than for VD. CONCLUSION: VDS is twice more effective than VD and displays a better cost per success. Additional studies are needed to clarify maintenance treatment, impact on quality of life, treatment of non-plaque psoriasis. It will be important to harmonize outcome measures in future studies with topical agents in psoriasis to better appraise their efficacy.


Assuntos
Psoríase/tratamento farmacológico , Vitamina D/uso terapêutico , Administração Tópica , Ensaios Clínicos como Assunto , Análise Custo-Benefício , Humanos , Qualidade de Vida , Recidiva , Vitamina D/administração & dosagem , Vitamina D/análogos & derivados
3.
Clin Oncol (R Coll Radiol) ; 6(6): 381-4, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7873485

RESUMO

Despite major technological advances in the treatment of cancer, many patients are dissatisfied with conventional biomedical interventions. This is largely because they fail to resolve long term intractable problems such as chronic pain or stress. More emphasis is now being placed on quality of life. This shift in attitude has opened the door for complementary therapies as adjuvants to traditional models of cancer care. Changes within the NHS have facilitated this transition, by the creation of the 'internal market' and the development of central funding to individual clinical directorates. To exploit these opportunities, complementary, therapists must develop new skills and be prepared to adopt NHS standards of assessment to evaluate the efficacy of their work. Standards are a component of 'Quality assurance'. They are observable, achievable and measurable, and contribute towards an acceptable evaluation process. Standards are used by health care purchasers to assess which therapies should be made available to patients within the NHS. This paper describes the development of a massage service that has been integrated into the Hammersmith Oncology Department. The massage standard is seen to be fundamental and essential to the continued development and evaluation of the project.


Assuntos
Serviços Técnicos Hospitalares/organização & administração , Massagem/normas , Neoplasias/reabilitação , Serviço Hospitalar de Oncologia/organização & administração , Serviços Técnicos Hospitalares/economia , Serviços Técnicos Hospitalares/normas , Atitude do Pessoal de Saúde , Controle de Formulários e Registros , Saúde Holística , Humanos , Massagem/economia , Neoplasias/psicologia , Qualidade de Vida , Encaminhamento e Consulta , Terapia de Relaxamento , Reino Unido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA